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deficiency, reduced natural killer (NK)-cell activity (4)
Snell-Bagg mice and Ames dwarf mice repeatedly and an increase of B-cells associated with an increase 
show severe immunodeficiencies, affecting mostly the in T-suppressor cells have been described (5). Other
thym us-dependent lym phocyte system, probably  studies, however, failed to demonstrate similar data (6, 
caused by growth hormone deficiency. In  growth hor- g)> In adult patients with hormone deficiency,
mone-deficient children contradictory data on the im ­
mune status have been reported. We investigated in ­
dices of cellular im m unity in 22 adult patients w ith 
proven growth hormone deficiency in  comparison to 
those in  100 healthy volunteers. Cellular im m unity  
was assessed using total leukocyte count, percentage 
lymphocytes, and percentage and absolute numbers of 
CD3, CD4, CD8, CD19, and CD3~CD56+ (NK)-cells. Com­
parison revealed statistically significantly lower per­
centage and absolute number of NK-cells (P < 0.001). 
Except for a trend toward an increased CD4/CD8 ratio, 
no statistically significant differences for B- and T- 
lymphocytes could be observed. No correlation be-
no data are available yet. Therefore, we studied cellu­
lar immunity in adult patients with growth hormone 
deficiency.
PATIENTS AND METHODS
Twenty-two patients (15 female and 7 male; mean 
age, 42 years; range, 27-59 years) with growth hor­
mone deficiency were included in this study. The diag­
nosis of growth hormone deficiency was based on an 
arginine provocation test with a growth hormone peak 
concentration ^10 mU/liter and an IGF-I concentra-
of NK-cells are decreased. © me Academic Press Inc.
tween the percentage and absolute number of NK- ^an below the normal value corrected for age and sex.
cells, on one hand, and the duration of growth hor- Most patients {n — 17) had multiple pituitary deficien-
mone deficiency or prolactin level, on the other hand, c*es an(^  received adequate, hormonal replacement
could be demonstrated. In  a ll these respects men did therapy, except for growth hormone for the last 2
not d iffe r from  women. So, in  grow th hormone- years. The control group consisted of 100 healthy vol-
deficient adults the percentage and absolute number unteers (48 male and 52 female; mean age, 43 years;
range, 18-70 years).
--------------------------------------- In all patients the following parameters were stud­
ied; hemoglobin, white blood count (WBC), red blood 
INTRODUCTION count (RBC), thrombocytes, the percentage and abso-
Animal studies demonstrated that growth hormone lute number of lymphocytes, CD3+ (total T-lympho-
plays a role in the modulation of the immune response cytes), CD4+ (T-helper cells), CD8+ (T-suppressor
in mice. Two animal models of congenital hypopituita- cells), CD19+ (B-lymphocytes), and CD14+ cells (mono-
rism, the Snell—Bagg mouse and the Ames dwarf cytes) and CD3~CD56+ cells (NK-cells). Hematologic
mouse, have severe immunodeficiency affecting mostly indices were measured using a Technicon H I electronic
the thymus-dependent lymphocyte system (1). In a cell counter. The percentages of CD3-, CD4-, CD8-,
third model (DW/J dwarf mice) a selective defect in the CD14-, and CD19-positive cells and the NK-cells were
production of growth hormone and prolactin coexisted measured using flow cytometry and direct immmuno-
with a deficiency of CD4+CD8+ double-positive thymo- fluorescence.
The unpaired Student t test was used to comparecytes, which could be corrected by treatment with re­
combinant growth hormone (2). Growth hormone defi- Spearman
ciency also affects thymic immunoresponse in rats and correlation test was used for the within population 
dogs (3).
In untreated children with isolated growth hormone All patients signed informed
comparisons
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which was approved by the University Hospital Ethical 
Committee.
RESULTS
Growth hormone deficiency was mostly due to hy- 
pophysectomy for the treatment of a pituitary adeno­
ma. Other causes included M. Sheehan, trauma, cra- 
niopharyngeoma, and hypothalamic insufficiency (see 
Table 1).
Standard hematological analysis revealed no statis­
tically significant differences when the patients data 
were compared with the controls.
Comparison of indices of the cellular immunity of 
growth hormone-deficient patients with those of the 
control group revealed a statistically significant lower
percentage and absolute number of NK-cells (P < 
0.001) (Table 2). No statistically significant differences 
for B- and T-lymphocytes could be demonstrated be­
tween patients with growth hormone deficiency and 
the normal population, except for a trend to an in­
creased CD4/CD8 ratio (P = 0.053).
No statistical significant correlation between the 
number or percentage of NK-cells and the estimated 
duration of growth hormone deficiency or prolactin le­
vers could be demonstrated. In all these respects men 
did not differ from women.
DISCUSSION
This study revealed no differences in thymic-derived 
cells between the adults with growth hormone defx-
i«  'Mi mn
TABLE 1
Demographic Data
-| BbJ — '.T'X WW ■ .'-S. 4 ^ m p.* M 'U 1 *11 1 »-H- 1 1 ^#>1 T1 w* - ^  * /i*f1 ' I “ “• <'4 **V«. • t
Isufflciency of other pituitary axes
Years of
somatotropin
Cause of
somatotropin Posterior
Patient Birth date deficiency Sex deficiency Adrenal Thyroidal Gonadal lobe
1 10 Sept. 1948 46 Male Congenital No No No No
2 21 Oct. 1963 17 Female Hypophysectomy
(chromophobe
adenoma)
Yes Yes Yes Yes
3 4 July 1962 32 Female Congenital No Yes No No
4 2 March 1968 21 Female Thalamus
tumor
(irradiated)
No No Yes No
5 9 July 1943 25 Female M. Sheehan Yes Yes Yes No
6 29 Nov. 1952 12 Female Hypophysectomy
(chomophobe
adenoma)
Yes Yes Yes No
7 11 Nov. 1945 49 Female Congenital No Yes No No
8 15 Feb. 1940 4 Male Pituitary
tumor
Yes Yes Yes No
9 20 May 1956 19 Female Epipharynx
carcinoma
(irradiated)
Yes Yes Yes No
10 20 Sept. 1950 12 Female Hypothalamic
insufficiency
No Yes No No
11 23 Feb. 1968 12 Female Idiopathic No Yes Yes Yes
12 19 Sept. 1936 10 Female Hypophysectomy Yes Yes Yes Yes
13 2 May 1965 18 Female C ranioph arygeoni a Yes Yes Yes Yes
14 16 July 1961 24 Male C raniophary geoma Yes Yes Yes Yes
15 10 Jan. 1956 11 Female Hypophysectomy 
(M. Cushing)
Yes No No No
16 30 June 1941 7 Male Hypophysectomy
(pituitary
tumor)
Yes Yes Yes Yes
17 27 Aug. 1940 16 Male Hypophysectomy
(chromophobe
adenoma)
Yes Yes Yes No
18 9 March 1964 11 Male Trauma Yes Yes Yes No
19 2 Feb. 1967 17 Female Irradiation
(cerebral
tumor)
No Yes Yes Yes
20 17 June 1954 24 Female Hypophysectomy 
(pituitary tumor)
Yes Yes Yes No
21 6 March 1961 20 Female Trauma Yes Yes Yes No
22 27 Jan. 1941 3 Male Hypophys ecto my 
(M. Cushing)
• “ k < U  ‘ — * < S » ^  4 ** 4 '  P 41 ^  V » a ^  ^  |f f* ' ' ^ i *... . .
Yes
- T . k 1__ _ - 1. »<•.> ‘ 4 •» — i *
Yes Yes No
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TABLE 2
Cell Counts and Percentage of White Blood Cells
Lymphocytes, 
x 10°/liter
CD-3 positive cells 
x l09/liter %
CD4-positive cells CD8-positive cells
x 10ö/liter % x 109/liter %
mu ■■■ 1 1 1 il i i ' i i n
GHD Mean 2.4 1.75 73.8 1.14 47.5 0.66 28.5
25-75% 1.7-3.1 1.14-2.39 71-79 0.74-1.55 43-51 0.43-0.86 22-33
Normal Mean 2.1 1.4 72 0.8 42 0.7 35
25-75% 1.6-2.4 1.1—1.7 67-76 0.7-1.1 38-46 0.5-0.9 31-40
CD 19-positive cells CD14-positive cells CD3'
xlO’Tliter % x 10'Vliter c
{• j  - ■ -■ » iw iM n fc M i  j j i i ‘ Wir ~ 1 - --— j~~ T rrr j i i  ‘fr i--  •• "■ -■ ■ -
x l09/liter
— ‘ - *--- n  --,-iT, , j , m
GHD Mean 0.3 14.6 0.43 5.9 0.14**
25-75% 0.2-0.4 8-20 0.28-0.56 4.3-•6.8 0.09-0.18
Normal Mean 0.3 13 0.5 8.5 03**
25-75% 0.2-1 O (11-16) 0.18-0.92 4.0-■13.0 0.2-0.4
CD4/CD8 ratio
1.99
1.34-2.58
1 .2
1 .0- 1 .5
cells
%
6 .2 ** 
4.0-9.0
14**
10-19
» iM'Wmi I
* Statistically significant difference, P < 0.001 (Student t test).
** Statistically significant difference, P < 0.001 growth hormone deficient patients vs controls (Student t test).
ciency and the normal population. The number and 2. Murphy, W. J., Drum, S. K , and Longo, D. L., Differential ef-
percentage of B-cells are also comparable with the val­
ues found in the normal population. Remarkably the 
number and percentage of NK-cells were significantly 
lower in the patient group than in the normal popula­
tion.
Hyperprolactinemia has been shown to inhibit im­
mune function (3); moreover, in hyperprolactinemic 
men, a reduced NK-cell activity was demonstrated 
compared to hyperprolactinemic patients treated with
bromocriptine (7), but these findings could not be re- 6. Spadoni, G. L., Rossi, P., Galli, E., Cianfarani, S., Gallaso, C.,
fects of growth hormone and prolactine on murine T cell devel­
opment and function. J. Exp. Med. 178(1), 231-236, 1993.
3. Kelly, K. W., Growth hormone, lymphocytes and macrophages.
Biochem Pharmacol. 38(5), 705-713, 1989.
4. Kiess, W., Doerr, H., Eisl, E., Butenandt, O., and Belohradsky, 
B. H., Lymphocytes subsets and natural killer activity in growth 
hormone deficiency (Letter). N. Engl. J. Med. 314, 321, 1986.
5. Gupta, S., Fikrig, S. M., and Novel, M. S., Immunological studies 
in patients with isolated growth hormone deficiency. Clin. Exp, 
Immunol. 54, 87-90, 1983.
produced (8). In our study we could not demonstrate a 
correlation between the absolute number of NK-cells 
and the prolactin concentration. Therefore, we con­
sider growth hormone deficiency as a possible cause for 
the decrease found in number and percentage NK-
cells.
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